Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

1.

Ceragenins: a class of antiviral compounds to treat orthopox infections.

Howell MD, Streib JE, Kim BE, Lesley LJ, Dunlap AP, Geng D, Feng Y, Savage PB, Leung DY.

J Invest Dermatol. 2009 Nov;129(11):2668-75. doi: 10.1038/jid.2009.120. Epub 2009 Jun 11.

PMID:
19516269
[PubMed - indexed for MEDLINE]
Free Article
2.

Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.

Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, Leung DY.

Immunity. 2006 Mar;24(3):341-8.

PMID:
16546102
[PubMed - indexed for MEDLINE]
Free Article
3.

Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances.

Smee DF, Bailey KW, Wong MH, Tarbet EB.

Antivir Chem Chemother. 2011 May 12;21(5):201-8. doi: 10.3851/IMP1734.

PMID:
21566266
[PubMed - indexed for MEDLINE]
4.

Skin inflammation in RelB(-/-) mice leads to defective immunity and impaired clearance of vaccinia virus.

Freyschmidt EJ, Mathias CB, MacArthur DH, Laouar A, Narasimhaswamy M, Weih F, Oettgen HC.

J Allergy Clin Immunol. 2007 Mar;119(3):671-9.

PMID:
17336617
[PubMed - indexed for MEDLINE]
5.

Treatment of poxvirus infections in rabbits with 9-beta-D-arabinofuranosyladenine.

Klein RJ, Friedman-Kien AE, Brady E.

Antimicrob Agents Chemother. 1974 Apr;5(4):409-12.

PMID:
15825397
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain.

Bin L, Howell MD, Kim BE, Hall CF, Streib JE, Leung DY.

J Allergy Clin Immunol. 2009 Aug;124(2):270-7, 277.e1. doi: 10.1016/j.jaci.2009.05.002. Epub 2009 Jul 3.

PMID:
19577285
[PubMed - indexed for MEDLINE]
7.

Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus.

Smee DF, Humphreys DE, Hurst BL, Barnard DL.

Antivir Chem Chemother. 2008;19(1):15-24.

PMID:
18610554
[PubMed - indexed for MEDLINE]
8.

Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus.

Kim BE, Leung DY, Streib JE, Kisich K, Boguniewicz M, Hamid QA, Howell MD.

J Allergy Clin Immunol. 2007 Feb;119(2):457-63. Epub 2006 Dec 4. Erratum in: J Allergy Clin Immunol. 2008 Nov;122(5):1007.. Kisich, Kevin [added].

PMID:
17141855
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Evaluation of imiquimod for topical treatment of vaccinia virus cutaneous infections in immunosuppressed hairless mice.

Tarbet EB, Larson D, Anderson BJ, Bailey KW, Wong MH, Smee DF.

Antiviral Res. 2011 Jun;90(3):126-33. doi: 10.1016/j.antiviral.2011.03.181. Epub 2011 Mar 23.

PMID:
21439326
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Antiviral activity of selected antimicrobial peptides against vaccinia virus.

Mohan KV, Rao SS, Atreya CD.

Antiviral Res. 2010 Jun;86(3):306-11. doi: 10.1016/j.antiviral.2010.03.012. Epub 2010 Mar 27.

PMID:
20347875
[PubMed - indexed for MEDLINE]
11.

Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum.

Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY.

J Immunol. 2004 Feb 1;172(3):1763-7.

PMID:
14734759
[PubMed - indexed for MEDLINE]
Free Article
12.

IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17.

Kohyama S, Ohno S, Isoda A, Moriya O, Belladonna ML, Hayashi H, Iwakura Y, Yoshimoto T, Akatsuka T, Matsui M.

J Immunol. 2007 Sep 15;179(6):3917-25.

PMID:
17785829
[PubMed - indexed for MEDLINE]
Free Article
13.

In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections.

Quenelle DC, Keith KA, Kern ER.

Antiviral Res. 2006 Aug;71(1):24-30. Epub 2006 Mar 29.

PMID:
16621041
[PubMed - indexed for MEDLINE]
14.

Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Wang Z, Lai Y, Bernard JJ, Macleod DT, Cogen AL, Moss B, Di Nardo A.

J Immunol. 2012 Jan 1;188(1):345-57. doi: 10.4049/jimmunol.1101703. Epub 2011 Dec 2.

PMID:
22140255
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative.

Ikeda S, Yazawa M, Nishimura C.

Antiviral Res. 1987 Oct;8(3):103-13.

PMID:
2827566
[PubMed - indexed for MEDLINE]
16.

Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.

Kawakami Y, Tomimori Y, Yumoto K, Hasegawa S, Ando T, Tagaya Y, Crotty S, Kawakami T.

J Exp Med. 2009 Jun 8;206(6):1219-25. doi: 10.1084/jem.20082835. Epub 2009 May 25.

PMID:
19468065
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Antiviral activity of Solanum paniculatum extract and constituents.

Valadares YM, Brandão'a GC, Kroon EG, Filho JD, Oliveira AB, Braga FC.

Z Naturforsch C. 2009 Nov-Dec;64(11-12):813-8.

PMID:
20158151
[PubMed - indexed for MEDLINE]
18.

[Synthesis and antiviral evaluation against Vaccinia virus of new N¹-oxide analogues of 5'-noraristeromycin].

Matiugina ES, Seley-Radtke KL, Andronova VL, Galegov GA, Kochetkov SN, Khandazhinskaia AL.

Bioorg Khim. 2010 Nov-Dec;36(6):797-801. Russian.

PMID:
21317946
[PubMed - indexed for MEDLINE]
19.

Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice.

Neyts J, De Clercq E.

Antimicrob Agents Chemother. 2001 Jan;45(1):84-7.

PMID:
11120949
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin.

Fisher RW, Reed JL, Snoy PJ, Mikolajczyk MG, Bray M, Scott DE, Kennedy MC.

Clin Vaccine Immunol. 2011 Jan;18(1):67-74. doi: 10.1128/CVI.00280-10. Epub 2010 Nov 24.

PMID:
21106779
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk